Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $6.03 USD
Change Today -0.01 / -0.17%
Volume 131.4K
TNXP On Other Exchanges
As of 5:20 PM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Seth Lederman M.D.

Co-Founder, Chairman, Chief Executive Officer and President, Tonix Pharmaceuticals Holding Corp
AgeTotal Calculated CompensationThis person is connected to 11 board members in 1 different organizations across 1 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Seth Lederman, M.D., co-founded Tonix Pharmaceuticals Holding Corp. Dr. Lederman has been the Chairman, Chief Executive Officer and President of Tonix Pharmaceuticals Holding Corp. since October 7, 2011. He is a physician, scientist and specialty pharmaceuticals entrepreneur. From 2007 to 2008, he co-founded and served as a Managing Partner of Konanda Pharma Partners and Konanda Pharma Fund I, LP, and Co-founded and served as director and chairman of its wholly owned ...

Read Full Background

Corporate Headquarters*

509 Madison Avenue
New York, New York 10022

United States

Phone: 212-980-9155
Fax: 212-923-5700

Board Members Memberships*

Co-Founder, Chairman, Chief Executive Officer and President


BA 1979
Princeton University
MD 1983
Edward S. Harkness Eye Institute

Other Affiliations*

Annual Compensation*

Total Annual Compensation$541,875

Stock Options*

All Other Compensation$37,723
Exercisable Options71,385
Unexercisable Options302,115
Total Number of Options373,500

Total Compensation*

Total Annual Cash Compensation$579,598
Total Short Term Compensation$541,875
Other Long Term Compensation$37,723
Total Calculated Compensation$2,853,578
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TNXP:US $6.03 USD -0.01


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TONIX PHARMACEUTICALS HOLDIN, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at